Reporter: Aviva Lev-Ari, PhD, RN
DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James Shen, PhD
April 22, 2013 by 2012pharmaceutical
Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Signaling & Cell Circuits, Chemical Genetics, Computational Biology/Systems and Bioinformatics, Genome Biology | 3 Comments
3 Responses
Leave a Reply Cancel reply
-
Recent Posts
- National Resilience, Inc. is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption – the Acquisition of Two Premier Biologics Manufacturing Facilities: Boston and in Ontario, Canada March 4, 2021
- 19 of the 49 New Therapeutic Molecular Entities FDA approved in 2020 — as well as a new Cell-based therapy — are Personalized Medicines March 2, 2021
- Happy 80th Birthday: Radioiodine (RAI) Theranostics: Collaboration between Physics and Medicine, the Utilization of Radionuclides to Diagnose and Treat: Radiation Dosimetry by Discoverer Dr. Saul Hertz, the early history of RAI in diagnosing and treating Thyroid diseases and Theranostics March 2, 2021
- 2.0 LPBI is a Very Unique Organization March 2, 2021
- FDA emergency use authorization would bring the public a third vaccine for the novel coronavirus – J&J single vaccine – Authorized on 2/28/2021 March 1, 2021
- Medical Device Representatives coach Surgeons in the Operating Rooms March 1, 2021
- 2021 Virtual World Medical Innovation Forum, Mass General Brigham, Gene and Cell Therapy, VIRTUAL May 19–21, 2021 February 26, 2021
- Inhibitory CD161 receptor recognized as a potential immunotherapy target in glioma-infiltrating T cells by single-cell analysis February 20, 2021
- First single-course ‘curative’ CRISPR Shot by Intellia rivals Alnylam, Ionis and Pfizer February 19, 2021
- Contribution of Nervous System Functional Deterioration to late-life Mortality: The Role Neurofilament light chain (NfL) a Blood Biomarker for the Progression of Neurological Diseases and its Correlation to Age and Life Expectancy February 19, 2021
Archives
Categories
Meta
-
2012pharmaceutical
-
Amandeep Kaur
-
Aashir Awan, Phd
-
Adina Hazan
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Daniel Menzin
-
Dror Nir
-
dsmolyar
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jayzmit48
-
jdpmd
-
jshertok
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
Madison Davis
-
marzankhan
-
megbaker58
-
ofermar2020
-
Dr. Pati
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
This again raises questions in my mind about methyl donor deficiency (methionine) and cancer resistance. Prof. Yves Ingenbleek did not investigate it, but he was not unaware of this. This is perhaps the other side of the coin with veganism.
[…] DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James… […]
[…] https://pharmaceuticalintelligence.com/2013/04/22/dna-methultransferases-implications-to-epigenetic-r… […]